vaccine manufacture

Home - Posts tagged: vaccine manufacture

A recombinant vaccine based on i-Particles is protective against H1N1 influenza infection

Tetrahymena cell
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection Context Cilian AG (Germany), affiliated as well as Adjuvatis, to the European consortium ADITEC, lead the production of a recombinant influenza haemagglutinin, using the ciliated protozoan Tetrahymena thermophila. Combined with NOD2 i-Particles, this H1N1 recombinant vaccine is protective against influenza protection.[...]
Read More